<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Anesthesia Progress Blog &#187; Therapeutics  Society</title>
	<atom:link href="http://www.anesthesiaprogress.com/tag/therapeutics-society/feed" rel="self" type="application/rss+xml" />
	<link>http://www.anesthesiaprogress.com</link>
	<description>Blog invites submissions of review articles, reports on clinical techniques, case reports, conference summaries, and articles of opinion pertinent to the control of pain and anxiety in dentistry.</description>
	<lastBuildDate>Sun, 11 Jul 2010 11:29:15 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Pharmacy &amp; Therapeutics  Society: PANEL DISCUSSION</title>
		<link>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-panel-discussion-2.html</link>
		<comments>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-panel-discussion-2.html#comments</comments>
		<pubDate>Sat, 22 May 2010 08:41:23 +0000</pubDate>
		<dc:creator>Andrew</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Pharmacy]]></category>
		<category><![CDATA[Therapeutics  Society]]></category>

		<guid isPermaLink="false">http://www.anesthesiaprogress.com/?p=1477</guid>
		<description><![CDATA[Challenges in Formulary Management Across Patient Populations and Practice Settings
Moderator: Perry Cohen, PharmD, The Pharmacy Group, LLC, Glastonburg, Connecticut.
Representatives from diverse practice settings described their process for formulary management within their individual practice settings.
Speaker: Joseph B. Fox, MD, Vice President, The Healthcare Group
The Healthcare Group, a provider-owned regional health plan, develops and maintains direct relationships [...]]]></description>
		<wfw:commentRss>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-panel-discussion-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmacy &amp; Therapeutics  Society: KEYNOTE SESSION</title>
		<link>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-keynote-session.html</link>
		<comments>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-keynote-session.html#comments</comments>
		<pubDate>Fri, 21 May 2010 08:41:23 +0000</pubDate>
		<dc:creator>Andrew</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Pharmacy]]></category>
		<category><![CDATA[Therapeutics  Society]]></category>

		<guid isPermaLink="false">http://www.anesthesiaprogress.com/?p=1476</guid>
		<description><![CDATA[Health Policy Update
Speaker: Rex Cowdry, MD, MPH, Associate Director, National Economic Council.
The market for health care poses a number of challenges for proponents of competitive markets, even though the markets have immensely desirable features in terms of incentives to enhance quality, control costs, and develop innovative approaches to treatment and to the organization and financing [...]]]></description>
		<wfw:commentRss>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-keynote-session.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmacy &amp; Therapeutics  Society: GENERAL SESSIONS</title>
		<link>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-general-sessions.html</link>
		<comments>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-general-sessions.html#comments</comments>
		<pubDate>Thu, 20 May 2010 08:41:21 +0000</pubDate>
		<dc:creator>Andrew</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Pharmacy]]></category>
		<category><![CDATA[Therapeutics  Society]]></category>

		<guid isPermaLink="false">http://www.anesthesiaprogress.com/?p=1475</guid>
		<description><![CDATA[The Impact of P&#38;T Committee Decision Strategies: Prescription to Over-the-Counter Switches
Speaker: Celynda Tadlock, PharmD, MBA, Director of Corporate Clinical Business Operations, Wellpoint Pharmacy Management, West Hills, California.
Over-the-counter (OTC) drugs are an undervalued resource for several reasons:

They are easily accessible to consumers.
They are at least as effective as many prescribed drugs.
The FDA&#8217;s standards for approving OTC [...]]]></description>
		<wfw:commentRss>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-general-sessions.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmacy &amp; Therapeutics  Society: The P&amp;T Society Working Group Findings</title>
		<link>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-the-pt-society-working-group-findings.html</link>
		<comments>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-the-pt-society-working-group-findings.html#comments</comments>
		<pubDate>Wed, 19 May 2010 08:41:21 +0000</pubDate>
		<dc:creator>Andrew</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Pharmacy]]></category>
		<category><![CDATA[Therapeutics  Society]]></category>

		<guid isPermaLink="false">http://www.anesthesiaprogress.com/?p=1474</guid>
		<description><![CDATA[Speaker: Burton Orland, RPh, Vice President of Pharmacy, Oxford Health Plans, Inc.
There is an opportunity for improving health care for patients with the following chronic diseases: asthma, diabetes, and dyslipidemia. In keeping with the PTS report, the &#8220;practice of excellence&#8221; in patient care would involve selecting the appropriate medication and developing and implementing programs aimed [...]]]></description>
		<wfw:commentRss>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-the-pt-society-working-group-findings.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmacy &amp; Therapeutics  Society: PANEL DISCUSSION</title>
		<link>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-panel-discussion.html</link>
		<comments>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-panel-discussion.html#comments</comments>
		<pubDate>Tue, 18 May 2010 08:41:33 +0000</pubDate>
		<dc:creator>Andrew</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Pharmacy]]></category>
		<category><![CDATA[Therapeutics  Society]]></category>

		<guid isPermaLink="false">http://www.anesthesiaprogress.com/?p=1473</guid>
		<description><![CDATA[The P&#38;T Society&#8217;s Response to the Institute of Medicine&#8217;s Reports
Moderator: Joseph Eichenholz, Managing Director, Tri-genesis Management Systems, Chatham, New Jersey. (See Mr. Eichenholz&#8217; overview on page 439.)
Speaker: Michael B. Nichol, PhD, Associate Professor and Chair, Department of Pharmaceutical Economics and Policy, University of Southern California School of Pharmacy, Los Angeles, California
Patient safety and medical and [...]]]></description>
		<wfw:commentRss>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-panel-discussion.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmacy &amp; Therapeutics  Society: KEYNOTE ADDRESS</title>
		<link>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-keynote-address.html</link>
		<comments>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-keynote-address.html#comments</comments>
		<pubDate>Mon, 17 May 2010 08:41:18 +0000</pubDate>
		<dc:creator>Andrew</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Pharmacy]]></category>
		<category><![CDATA[Therapeutics  Society]]></category>

		<guid isPermaLink="false">http://www.anesthesiaprogress.com/?p=1472</guid>
		<description><![CDATA[The Institute of Medicine&#8217;s Agenda for Health Care Quality: Past, Present, and Future
Keynote Speaker: Harvey V. Fineberg, MD, PhD, President, Institute of Medicine.
The pathways to improving the quality of health care in the U.S. involve two strategies: developing better drug interventions and devising better ways to do things using existing technologies.
Dr. Fineberg cited the IOM [...]]]></description>
		<wfw:commentRss>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society-keynote-address.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmacy &amp; Therapeutics  Society</title>
		<link>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society.html</link>
		<comments>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society.html#comments</comments>
		<pubDate>Sun, 16 May 2010 09:02:22 +0000</pubDate>
		<dc:creator>Andrew</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Pharmacy]]></category>
		<category><![CDATA[Therapeutics  Society]]></category>

		<guid isPermaLink="false">http://www.anesthesiaprogress.com/?p=1471</guid>
		<description><![CDATA[PRESIDENT&#8217;S ADDRESS
The Value of Therapy: The Role of the P&#38;T Society
Speaker: J. Lyle Bootman, PhD, President, P&#38;T Society.
Drug-related morbidity and mortality represent a &#8220;silent disease in America.&#8221; The value of the quality of health care depends on the accessibility of medicine to patients and on the cost of medicine. The Institute of Medicine (IOM) is [...]]]></description>
		<wfw:commentRss>http://www.anesthesiaprogress.com/pharmacy-therapeutics-society.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

